目的:观察咪达唑仑对人胚肾上皮细胞(HEK-293)中异源表达的人类相关基因(h ERG)钾电流作用及其机制。方法:利用全细胞膜片钳技术,观察咪达唑仑对h ERG钾通道的抑制作用,分析其对通道激活、失活动力学过程的影响以及咪达唑仑对Y652A和F656C突变型h ERG钾通道的作用。结果:咪达唑仑浓度依赖性地抑制h ERG钾电流,其IC50值为(1.31±0.32)μmol/L。1.0μmol/L的咪达唑仑加药前后半数激活电压V1/2由(2.32±0.38)m V变为(-1.96±0.83)m V;加药前后半数失活电压V1/2由(-49.25±0.69)m V变为(-57.53±0.53)m V(P〈0.05),失活曲线左移;与野生型(WT)比较,Y652A和F656C突变型可显著减弱咪达唑仑对h ERG通道的阻断作用。结论:咪达唑仑能阻断h ERG钾通道,失活速度加快,Y652和F656可能是咪达唑仑与h ERG钾通道结合的关键位点。
Objective: To investigate the effect of midazolam on human ether-a-go-go (bERG) K + channels exogenously expressed in hu- man embryonic kidney cells (HEK-293) and the underlying molecular mechanisms. Methods: Whole-ccll patch clamp technique was used to record WT, Y652A and F656C bERG K+ curium expressed in HEK-293 cells. Results: Midazolam inhibited hERG K+ current in a concen- tration-dependent manner, the half-maximum block concentrations ( IC50 ) values were ( 1.31 ±0.32) μmol/L. The half-activation voltage (V1/2) were (2.32 ± 0.38) mV for the control and (-1.96 ± 0.83) mY for 1.0 tmaol/L midazolam. The half-inactivation voltage (Vl/2) was slightly shifted towards negative voltages from (-49.25 ± 0.69) mV in control to (-57.53 ± 0.53) mV after 1.0 μmol/L midazolam ( P 〈 0.05). Mutations in drug-binding sites (Y652A or F656C) of the bERG charmel significantly attenuated the bERG current blockade by mida- zolam. Conclusion: Midazolam can block hERG K + channel and cause the speed of inactivation faster. Mutations in the drug-binding sites (Y652 or F656) of the bERG channel were found to attenuate hERG current blockage by midazolam,